XGN — EXAGEN INC.
—
Nasdaq ·
Health Care ·
Health Care Providers & Services ·
CIK 1274737 ·
Last close
$4.53
Market Cap
$109.44M
52W High
$5.55
52W Low
$2.82
ADV30
218,387
Next earnings
2026-08-04
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 17,306,000 | 10,205,000 | -3,414,000 | -3,967,000 | 51,957,000 | 21,513,000 | 37,525,000 |
| Dec 2025 | 16,631,000 | 9,206,000 | -4,975,000 | -4,673,000 | 58,022,000 | 32,220,000 | 40,573,000 |
| Sep 2025 | 17,244,000 | 10,075,000 | -3,100,000 | -7,087,000 | 62,823,000 | 35,652,000 | 44,685,000 |
| Jun 2025 | 17,202,000 | 10,395,000 | -2,630,000 | -4,439,000 | 58,760,000 | 30,033,000 | 37,726,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-13,371,000
Investing CF
$-747,000
Financing CF
$24,437,000
CapEx
$-756,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.89
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-314,282,000
Inventory
—
Receivables
$10,855,000
ST Investments
—
EBIT TTM
$-15,582,000
Pretax Income TTM
$-19,900,000
Interest Exp TTM
$4,318,000
Analysts
6
Yahoo Snapshot (yfinance, live)
Total Revenue
$68,383,000
EBITDA
$-11,842,000
Free Cash Flow
$-9,068,375
Enterprise Value
$115,077,072
Total Cash
$21,513,000
Total Debt
$27,146,000
Shares Out
24,159,839
Trailing EPS
$-0.90
Book Value
$0.60
ROE
-193.6%
ROA
-19.1%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 66,575,000 | -14,070,000 | -19,951,000 | 58,022,000 | 40,573,000 | — | -13,625,000 |
| Dec 2024 | 55,641,000 | -13,636,000 | -15,115,000 | 44,689,000 | 35,149,000 | — | -13,279,000 |
| Dec 2023 | 52,548,000 | -22,837,000 | -23,689,000 | 56,944,000 | 34,250,000 | — | -14,462,000 |
| Dec 2022 | 45,563,000 | -40,545,000 | -47,387,000 | 86,221,000 | 43,761,000 | — | -32,144,000 |
TTM Snapshot
Revenues TTM
$52,900,000
NetIncome TTM
$-25,718,000
OpCashFlow TTM
$0
Assets (Latest)
$44,689,000
Forward EPS
$-0.43
Max Pain — expiry 2026-10-16 (volume-derived — Yahoo OI feed degraded)
max pain strike: $2.50 · spot: $4.53 · call volume: 5 · put volume: 1
Expected Move to 2026-10-16:
±$2.45
(54.08%) —
implied range
$2.08 –
$6.98
· ATM straddle on $5.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| PCSC | Freenome, Inc. | $97.68M | $11.98 | — |
| PARK | Park Dental Partners, Inc. | $80.73M | $17.88 | — |
| BNR | Burning Rock Biotech Ltd | $78.44M | $8.90 | — |
| AUNA | AUNA S.A. | $152.80M | $5.07 | — |
| YDES | YD Bio Ltd | $153.70M | $2.17 | — |
News headlines (Yahoo Finance, 1h cache)
Exagen Inc. to Participate in Upcoming Investor Conference
2026-07-28 13:00 · Yahoo
Exagen to Announce Second Quarter Financial Results on August 4, 2026
2026-07-21 13:00 · Yahoo
Exagen (XGN) Stock Draws Fresh Price Target Split After Analysts Trim Targets
2026-06-19 04:33 · Yahoo
Exagen Announces Publication of Systematic Review Confirming Robust Real-World Performance of AVISE Lupus
2026-06-01 13:00 · Yahoo
How Much Upside is Left in Exagen (XGN)? Wall Street Analysts Think 73.05%
2026-05-28 13:55 · Yahoo
The Exagen Inc. (NASDAQ:XGN) First-Quarter Results Are Out And Analysts Have Published New Forecasts
2026-05-14 11:15 · Yahoo
Exagen (XGN) Q1 2026 Earnings Transcript
2026-05-12 18:16 · Yahoo
Exagen Inc. Q1 2026 Earnings Call Summary
2026-05-12 12:30 · Yahoo
Exagen Inc (XGN) Q1 2026 Earnings Call Highlights: Record Revenue and Strategic Growth Amid ...
2026-05-12 07:02 · Yahoo
Exagen Q1 Earnings Call Highlights
2026-05-11 17:09 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.